BRITTANY WEED: Open Payments
NPI 1538779996 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 35 payments from 13 companies in 2025. Trend: 2023 $159 · 2024 $564 · 2025 $710
Food & beverage: $610Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $183 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 7 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Tempus AI, Inc | 2 | $51 |
| Lilly USA, LLC | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| ARRAY BIOPHARMA INC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
Products named: ENHERTU, XT CDX, VERZENIO, DATROWAY, JEMPERLI, IBRANCE, INJECTAFER, Nubeqa.
Industry payments across UT — which companies pay providers there.
